Finally, we carried out a proteomic analysis of two GCN2-independent cancer cell lines and HUVECs after GCN2 inhibition and observed that GCN2 inhibition had essentially no effect on the proteome of these cells (Fig S6A–D). The gene discussed is EIF2AK4; the disease is cancer.